S. Jiao

发表

Case report: sequential use of almonertinib based on the EGFR exon 20 insertion mutation achieves long-term control for advanced non-small cell lung cancer patients

Jiuzhou Zhao, Qiming Wang, Yufeng Wu, 2021, Translational cancer research.

Genetic Alteration and Their Significance on Clinical Events in Small Cell Lung Cancer

Xin Zhang, S. Jiao, Q. Xia, 2022, Cancer management and research.

Functional Role of NRF2 in Cervical Carcinogenesis

S. Jiao, Jun Ma, Hatila Tuersun, 2015, PloS one.

Defective expression of polarity protein Par3 promotes cervical tumorigenesis and metastasis.

S. Wang, S. Zheng, S. Jiao, 2015, European journal of gynaecological oncology.

Long-Term Survival of PD-1 Inhibitor Combined with Antiangiogenic Agents in a Patient with Pulmonary Sarcomatoid Carcinoma Complicated with Esophageal Cancer: A Case Resport and Literature Review

Xiao Zhang, Hui Zhu, Rui-lin Wang, 2021 .

Case Report: A good response to furmonertinib second-line treatment of an advanced lung adenocarcinoma patient with a rare EGFR exon 20 N771_P772insH mutation: A case report and literature review

Xiang Li, Jiuzhou Zhao, X. Li, 2022, Frontiers in Pharmacology.

Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma

Jianwei Yang, Qiming Wang, Xuan Wu, 2019, Front. Oncol..

CMAR_A_356037 1493..1505

Xin Zhang, S. Jiao, Q. Xia, 2022 .

Evolution of Lung Cancer in the Context of Immunotherapy

Qiming Wang, Xuan Wu, Yufeng Wu, 2020, Clinical Medicine Insights. Oncology.